These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 25704890

  • 1. Ritonavir-boosted indinavir but not lopinavir inhibits erythrocytic stage Plasmodium knowlesi malaria in rhesus macaques.
    Qin L, Qin L, Xu W, Zhao S, Chen X.
    Bioorg Med Chem Lett; 2015 Apr 01; 25(7):1538-40. PubMed ID: 25704890
    [Abstract] [Full Text] [Related]

  • 2. Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques.
    Li Y, Qin L, Peng N, Liu G, Zhao S, He Z, Chen X.
    Antimicrob Agents Chemother; 2011 Jun 01; 55(6):3039-42. PubMed ID: 21486958
    [Abstract] [Full Text] [Related]

  • 3. HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.
    Hobbs CV, Neal J, Conteh S, Donnelly L, Chen J, Marsh K, Lambert L, Orr-Gonzalez S, Hinderer J, Healy S, Borkowsky W, Penzak SR, Chakravarty S, Hoffman SL, Duffy PE.
    PLoS One; 2014 Jun 01; 9(7):e100138. PubMed ID: 24988386
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiretrovirals as antimalarial agents.
    Skinner-Adams TS, McCarthy JS, Gardiner DL, Hilton PM, Andrews KT.
    J Infect Dis; 2004 Dec 01; 190(11):1998-2000. PubMed ID: 15529265
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys.
    Tripathi R, Mishra D, Rizvi A, Singh C.
    Life Sci; 2007 Nov 10; 81(21-22):1544-8. PubMed ID: 17976659
    [Abstract] [Full Text] [Related]

  • 7. Characterization of simian malarial parasite (Plasmodium knowlesi)-induced putrescine transport in rhesus monkey erythrocytes. A novel putrescine conjugate arrests in vitro growth of simian malarial parasite (Plasmodium knowlesi) and cures multidrug resistant murine malaria (Plasmodium yoelii) infection in vivo.
    Singh S, Puri SK, Singh SK, Srivastava R, Gupta RC, Pandey VC.
    J Biol Chem; 1997 May 23; 272(21):13506-11. PubMed ID: 9153195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity.
    Bailey BL, Nguyen W, Ngo A, Goodman CD, Gancheva MR, Favuzza P, Sanz LM, Gamo FJ, Lowes KN, McFadden GI, Wilson DW, Laleu B, Brand S, Jackson PF, Cowman AF, Sleebs BE.
    Bioorg Chem; 2021 Oct 23; 115():105244. PubMed ID: 34452759
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo culture of Plasmodium vivax and Plasmodium cynomolgi and in vitro culture of Plasmodium knowlesi blood stages.
    Zeeman AM, der Wel AV, Kocken CH.
    Methods Mol Biol; 2013 Oct 23; 923():35-49. PubMed ID: 22990770
    [Abstract] [Full Text] [Related]

  • 11. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
    Nguyen W, Dans MG, Ngo A, Gancheva MR, Romeo O, Duffy S, de Koning-Ward TF, Lowes KN, Sabroux HJ, Avery VM, Wilson DW, Gilson PR, Sleebs BE.
    Eur J Med Chem; 2021 Mar 15; 214():113253. PubMed ID: 33610028
    [Abstract] [Full Text] [Related]

  • 12. Plasmodium knowlesi in pig-tailed macaques: a potential new model for malaria vaccine research.
    Shears MJ, Reynolds RA, Duncombe CJ, Watson FN, Staubus WJ, Chavtur C, Seilie AM, Tran TM, Chakravarty S, Hoffman SL, Murphy SC.
    Malar J; 2023 Dec 13; 22(1):379. PubMed ID: 38093306
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simultaneous quantitation of HIV-protease inhibitors ritonavir, lopinavir and indinavir in human plasma by UPLC-ESI-MS-MS.
    Das Mishra T, Kurani H, Singhal P, Shrivastav PS.
    J Chromatogr Sci; 2012 Aug 13; 50(7):625-35. PubMed ID: 22562821
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai children.
    Plipat N, Cressey TR, Vanprapar N, Chokephaibulkit K.
    Pediatr Infect Dis J; 2007 Jan 13; 26(1):86-8. PubMed ID: 17195716
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors.
    Chetchotisakd P, Anunnatsiri S, Mootsikapun P, Kiertiburanakul S, Anekthananon T, Bowonwatanuwong C, Kowadisaiburana B, Supparatpinyo K, Ruxrungtham K, Study Team.
    HIV Med; 2007 Nov 13; 8(8):529-35. PubMed ID: 17944686
    [Abstract] [Full Text] [Related]

  • 18. Artemisinin derivatives bearing Mannich base group: synthesis and antimalarial activity.
    Li Y, Yang ZS, Zhang H, Cao BJ, Wang FD, Zhang Y, Shi YL, Yang JD, Wu BA.
    Bioorg Med Chem; 2003 Oct 01; 11(20):4363-8. PubMed ID: 13129573
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
    Dragsted UB, Gerstoft J, Pedersen C, Peters B, Duran A, Obel N, Castagna A, Cahn P, Clumeck N, Bruun JN, Benetucci J, Hill A, Cassetti I, Vernazza P, Youle M, Fox Z, Lundgren JD, MaxCmin1 Trial Group.
    J Infect Dis; 2003 Sep 01; 188(5):635-42. PubMed ID: 12934178
    [Abstract] [Full Text] [Related]

  • 20. Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring.
    Wasmuth JC, Rodermann E, Voigt E, Vogel M, Lauenroth-Mai E, Jessen A, Burger D, Rockstroh JK.
    Eur J Med Res; 2007 Jul 26; 12(7):289-94. PubMed ID: 17933700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.